{"hands_on_practices": [{"introduction": "The journey of a steroid hormone begins in the bloodstream, where it is largely bound to carrier proteins. The \"free hormone hypothesis\" posits that only the unbound fraction is biologically active, as it is free to diffuse across the cell membrane and engage with intracellular receptors. This exercise [@problem_id:2810983] provides a practical application of the law of mass action to a physiological scenario, challenging you to calculate the precise concentration of free, active cortisol from total plasma concentrations and binding affinities for its major carrier proteins. Mastering this calculation is key to understanding the link between systemic hormone levels and their effective concentration at the cellular target.", "problem": "Cortisol, a steroid hormone that signals via the intracellular glucocorticoid receptor (GR), circulates in plasma where it binds primarily to corticosteroid-binding globulin (CBG) with high affinity and to serum albumin (Alb) with lower affinity but very high abundance. At equilibrium in a well-mixed compartment, assume that cortisol binds independently and reversibly to a single site on each protein species with the law of mass action. The equilibrium dissociation constant is defined by $K_{d} = \\frac{[L][P]}{[LP]}$ for ligand $L$ and protein $P$, and total concentrations obey conservation, $[L]_{\\text{total}} = [L]_{\\text{free}} + \\sum [LP]$ and $[P]_{\\text{total}} = [P]_{\\text{free}} + [LP]$. Neglect any other binding partners or metabolism on the time scale considered.\n\nYou are given the following plasma values: $[\\text{cortisol}]_{\\text{total}} = 400\\,\\text{nM}$, $[\\text{CBG}]_{\\text{total}} = 1\\,\\mu\\text{M}$, $K_{d}^{\\text{CBG}} = 50\\,\\text{nM}$, $[\\text{Alb}]_{\\text{total}} = 600\\,\\mu\\text{M}$, and $K_{d}^{\\text{Alb}} = 150\\,\\mu\\text{M}$. Treat $[\\text{CBG}]_{\\text{total}}$ and $[\\text{Alb}]_{\\text{total}}$ as parameters fixed by plasma protein levels.\n\nUsing only the definitions above and conservation of mass, derive the equilibrium condition for $[\\text{cortisol}]_{\\text{free}}$ and compute the fraction of free cortisol $f_{\\text{free}} = \\frac{[\\text{cortisol}]_{\\text{free}}}{[\\text{cortisol}]_{\\text{total}}}$. Report $f_{\\text{free}}$ as a unitless decimal, rounding your answer to four significant figures.", "solution": "The problem as stated is scientifically grounded, well-posed, and objective. It presents a standard ligand-protein binding equilibrium problem that can be solved using the law of mass action and principles of mass conservation. All necessary parameters are provided, and their values are within a physiologically plausible range. Therefore, the problem is valid, and we may proceed with the derivation and solution.\n\nLet us denote the concentrations of free cortisol, corticosteroid-binding globulin (CBG), and serum albumin (Alb) as $[L]$, $[P_1]$, and $[P_2]$, respectively. The total concentrations are given as $[L]_{\\text{total}}$, $[P_1]_{\\text{total}}$, and $[P_2]_{\\text{total}}$. The cortisol-CBG complex is $[LP_1]$ and the cortisol-albumin complex is $[LP_2]$. The corresponding equilibrium dissociation constants are $K_{d,1}$ and $K_{d,2}$.\n\nThe problem is governed by the following set of equations based on mass conservation and the law of mass action:\n1. Conservation of total cortisol:\n$$[L]_{\\text{total}} = [L] + [LP_1] + [LP_2]$$\n2. Conservation of total CBG:\n$$[P_1]_{\\text{total}} = [P_1] + [LP_1]$$\n3. Conservation of total albumin:\n$$[P_2]_{\\text{total}} = [P_2] + [LP_2]$$\n4. Binding equilibrium for CBG:\n$$K_{d,1} = \\frac{[L][P_1]}{[LP_1]}$$\n5. Binding equilibrium for albumin:\n$$K_{d,2} = \\frac{[L][P_2]}{[LP_2]}$$\n\nFrom equation (2), we have $[P_1] = [P_1]_{\\text{total}} - [LP_1]$. Substituting this into equation (4):\n$$K_{d,1} = \\frac{[L]([P_1]_{\\text{total}} - [LP_1])}{[LP_1]}$$\nRearranging to solve for the concentration of the cortisol-CBG complex, $[LP_1]$:\n$$K_{d,1} [LP_1] = [L][P_1]_{\\text{total}} - [L][LP_1]$$\n$$[LP_1](K_{d,1} + [L]) = [L][P_1]_{\\text{total}}$$\n$$[LP_1] = \\frac{[L][P_1]_{\\text{total}}}{K_{d,1} + [L]}$$\nBy an identical derivation for albumin, we find the concentration of the cortisol-albumin complex, $[LP_2]$:\n$$[LP_2] = \\frac{[L][P_2]_{\\text{total}}}{K_{d,2} + [L]}$$\nNow, we substitute these expressions for $[LP_1]$ and $[LP_2]$ into the cortisol conservation equation (1). This yields the exact equilibrium condition for the free cortisol concentration, $[L]$:\n$$[L]_{\\text{total}} = [L] + \\frac{[L][P_1]_{\\text{total}}}{K_{d,1} + [L]} + \\frac{[L][P_2]_{\\text{total}}}{K_{d,2} + [L]}$$\nThis equation is a cubic polynomial in $[L]$ and is not readily solvable by simple analytical means. However, we are permitted to analyze the given parameters to determine if a scientifically sound approximation can be made.\n\nThe given values are:\n$[\\text{cortisol}]_{\\text{total}} = [L]_{\\text{total}} = 400\\,\\text{nM}$\n$[\\text{CBG}]_{\\text{total}} = [P_1]_{\\text{total}} = 1\\,\\mu\\text{M} = 1000\\,\\text{nM}$\n$K_{d}^{\\text{CBG}} = K_{d,1} = 50\\,\\text{nM}$\n$[\\text{Alb}]_{\\text{total}} = [P_2]_{\\text{total}} = 600\\,\\mu\\text{M} = 600000\\,\\text{nM}$\n$K_{d}^{\\text{Alb}} = K_{d,2} = 150\\,\\mu\\text{M} = 150000\\,\\text{nM}$\n\nWe observe that the dissociation constant for albumin, $K_{d,2}$, is very large ($150000\\,\\text{nM}$) compared to both $K_{d,1}$ ($50\\,\\text{nM}$) and the total cortisol concentration ($400\\,\\text{nM}$). This suggests that the free cortisol concentration $[L]$ will be much smaller than $K_{d,2}$. Therefore, in the denominator of the albumin binding term, it is reasonable to make the approximation $K_{d,2} + [L] \\approx K_{d,2}$. This corresponds to the case of a low-affinity, high-capacity binding protein where the concentration of free protein is approximately equal to its total concentration ($[P_2] \\approx [P_2]_{\\text{total}}$).\n\nApplying this approximation, the equilibrium condition simplifies to:\n$$[L]_{\\text{total}} \\approx [L] + \\frac{[L][P_1]_{\\text{total}}}{K_{d,1} + [L]} + \\frac{[L][P_2]_{\\text{total}}}{K_{d,2}}$$\nSubstituting the numerical values into this equation, letting $x = [L]$:\n$$400 = x + \\frac{x \\cdot 1000}{50 + x} + \\frac{x \\cdot 600000}{150000}$$\n$$400 = x + \\frac{1000x}{50 + x} + 4x$$\n$$400 = 5x + \\frac{1000x}{50 + x}$$\nTo solve for $x$, we multiply by $(50 + x)$ to clear the denominator:\n$$400(50 + x) = 5x(50 + x) + 1000x$$\n$$20000 + 400x = 250x + 5x^2 + 1000x$$\n$$5x^2 + (1250 - 400)x - 20000 = 0$$\n$$5x^2 + 850x - 20000 = 0$$\nDividing by $5$:\n$$x^2 + 170x - 4000 = 0$$\nThis is a standard quadratic equation of the form $ax^2 + bx + c = 0$, which we solve for $x$ using the quadratic formula, $x = \\frac{-b \\pm \\sqrt{b^2 - 4ac}}{2a}$:\n$$x = \\frac{-170 \\pm \\sqrt{170^2 - 4(1)(-4000)}}{2(1)}$$\n$$x = \\frac{-170 \\pm \\sqrt{28900 + 16000}}{2}$$\n$$x = \\frac{-170 \\pm \\sqrt{44900}}{2}$$\nSince concentration must be a positive quantity, we take the positive root:\n$$x = \\frac{-170 + \\sqrt{44900}}{2} = \\frac{-170 + 10\\sqrt{449}}{2} = -85 + 5\\sqrt{449}$$\nNumerically, this evaluates to:\n$$x \\approx 20.94803\\,\\text{nM}$$\nThis result confirms our initial assumption, as $x = 20.94803\\,\\text{nM} \\ll 150000\\,\\text{nM} = K_{d,2}$, justifying the approximation. Substitution of this value back into the original, un-approximated cubic equation confirms it is a highly accurate root.\n\nThe problem requires the calculation of the fraction of free cortisol, $f_{\\text{free}}$:\n$$f_{\\text{free}} = \\frac{[\\text{cortisol}]_{\\text{free}}}{[\\text{cortisol}]_{\\text{total}}} = \\frac{x}{[L]_{\\text{total}}}$$\n$$f_{\\text{free}} = \\frac{20.94803}{400} \\approx 0.052370075$$\nRounding to four significant figures, we get:\n$$f_{\\text{free}} \\approx 0.05237$$", "answer": "$$\n\\boxed{0.05237}\n$$", "id": "2810983"}, {"introduction": "A central goal in pharmacology and endocrinology is to characterize how various compounds, from endogenous molecules to synthetic drugs, interact with a receptor's ligand-binding domain. Competitive binding assays are a fundamental tool for this purpose, but interpreting their results requires careful analysis. This problem [@problem_id:2811040] guides you through the derivation of the seminal Cheng-Prusoff equation, which provides the crucial link between a competitor's intrinsic affinity ($K_i$) and its measured half-maximal inhibitory concentration ($IC_{50}$). By working through this derivation, you will gain a deeper understanding of how assay conditions influence experimental outcomes and how to properly quantify competitive inhibition.", "problem": "A nuclear receptor laboratory is quantifying competitive binding to the ligand-binding domain of the human glucocorticoid receptor, an intracellular receptor that mediates steroid hormone signaling. A radiolabeled agonist ligand at free concentration $[L] = 2\\,\\text{nM}$ and equilibrium dissociation constant $K_d = 1\\,\\text{nM}$ is used to measure specific binding at equilibrium. A test compound is a pure competitive antagonist that binds the same site with inhibition constant $K_i$.\n\nAssume a single noncooperative binding site, reversible equilibrium binding, and that $[L]$ is the free ligand concentration at equilibrium (receptor is in tracer amounts so ligand depletion is negligible). Define the half maximal inhibitory concentration ($IC_{50}$) of the antagonist as the concentration of antagonist that reduces the specific binding of the radiolabeled ligand to one-half of its value in the absence of antagonist, measured at the same $[L]$.\n\nStarting from the law of mass action and the definitions of the equilibrium dissociation constant ($K_d$) and inhibition constant ($K_i$), derive an explicit expression for the multiplicative shift factor $S \\equiv \\frac{IC_{50}}{K_i}$ as a function of $[L]$ and $K_d$. Then, evaluate $S$ numerically for $[L] = 2\\,\\text{nM}$ and $K_d = 1\\,\\text{nM}$. Express your final answer as a pure number with no units. No rounding is necessary.", "solution": "The problem statement is scientifically grounded, self-contained, and well-posed. It describes a standard competitive binding assay, a fundamental technique in biochemistry and pharmacology. All necessary constants, variables, and definitions are provided to derive the relationship requested. The problem is therefore deemed valid, and we shall proceed with its solution.\n\nThe core of the problem lies in the principles of chemical equilibrium governed by the law of mass action. Let $[R]$, $[L]$, and $[I]$ be the equilibrium concentrations of the free receptor, the free radiolabeled ligand, and the free antagonist inhibitor, respectively. The concentrations of the receptor-ligand complex and the receptor-inhibitor complex are $[RL]$ and $[RI]$. The total receptor concentration is $[R_T]$.\n\nThe system involves two simultaneous reversible equilibria for a competitive antagonist that binds to the same site as the ligand:\n$1$. Ligand binding: $R + L \\rightleftharpoons RL$, with the equilibrium dissociation constant $K_d = \\frac{[R][L]}{[RL]}$.\n$2$. Inhibitor binding: $R + I \\rightleftharpoons RI$, with the inhibition constant $K_i = \\frac{[R][I]}{[RI]}$.\n\nFrom these definitions, we can express the concentrations of the bound species in terms of the free concentrations:\n$[RL] = \\frac{[R][L]}{K_d}$\n$[RI] = \\frac{[R][I]}{K_i}$\n\nThe total concentration of the receptor, $[R_T]$, is the sum of the concentrations of all its forms: free, ligand-bound, and inhibitor-bound.\n$[R_T] = [R] + [RL] + [RI]$\n\nBy substituting the expressions for $[RL]$ and $[RI]$, we can express $[R_T]$ in terms of the free receptor concentration $[R]$:\n$[R_T] = [R] + \\frac{[R][L]}{K_d} + \\frac{[R][I]}{K_i} = [R] \\left( 1 + \\frac{[L]}{K_d} + \\frac{[I]}{K_i} \\right)$\n\nThe specific binding of the ligand, which is being measured, is directly proportional to the fractional occupancy of the receptor by the ligand, denoted as $\\theta_L$. The fractional occupancy is the ratio of the concentration of ligand-bound receptor to the total receptor concentration.\n$\\theta_L = \\frac{[RL]}{[R_T]}$\n\nIn the presence of an inhibitor at concentration $[I]$, the fractional occupancy, which we shall call $\\theta_I$, is:\n$\\theta_I = \\frac{[RL]}{[R] + [RL] + [RI]} = \\frac{\\frac{[R][L]}{K_d}}{[R] \\left( 1 + \\frac{[L]}{K_d} + \\frac{[I]}{K_i} \\right)} = \\frac{\\frac{[L]}{K_d}}{1 + \\frac{[L]}{K_d} + \\frac{[I]}{K_i}}$\n\nIn the absence of the inhibitor, $[I]=0$, and the fractional occupancy, denoted $\\theta_0$, is:\n$\\theta_0 = \\frac{\\frac{[L]}{K_d}}{1 + \\frac{[L]}{K_d}} = \\frac{[L]}{K_d + [L]}$\n\nThe problem defines the half maximal inhibitory concentration, $IC_{50}$, as the concentration of the antagonist, $[I] = IC_{50}$, at which the specific binding of the ligand is reduced to one-half of its value in the absence of the antagonist. This translates to the condition that the fractional occupancy in the presence of the inhibitor is half of the occupancy in its absence:\n$\\theta_I \\bigg|_{[I]=IC_{50}} = \\frac{1}{2} \\theta_0$\n\nWe substitute our derived expressions into this condition:\n$$ \\frac{\\frac{[L]}{K_d}}{1 + \\frac{[L]}{K_d} + \\frac{IC_{50}}{K_i}} = \\frac{1}{2} \\left( \\frac{[L]}{K_d + [L]} \\right) $$\nTo simplify, we can rewrite the term on the right-hand side:\n$$ \\frac{\\frac{[L]}{K_d}}{1 + \\frac{[L]}{K_d} + \\frac{IC_{50}}{K_i}} = \\frac{1}{2} \\left( \\frac{\\frac{[L]}{K_d}}{1 + \\frac{[L]}{K_d}} \\right) $$\nGiven that $[L]$ is a non-zero concentration, the term $\\frac{[L]}{K_d}$ is also non-zero and can be cancelled from the numerators of both sides of the equation.\n$$ \\frac{1}{1 + \\frac{[L]}{K_d} + \\frac{IC_{50}}{K_i}} = \\frac{1}{2 \\left( 1 + \\frac{[L]}{K_d} \\right)} $$\nInverting both sides of the equation leads to:\n$$ 1 + \\frac{[L]}{K_d} + \\frac{IC_{50}}{K_i} = 2 \\left( 1 + \\frac{[L]}{K_d} \\right) $$\n$$ 1 + \\frac{[L]}{K_d} + \\frac{IC_{50}}{K_i} = 2 + 2\\frac{[L]}{K_d} $$\nNow, we solve for the ratio $\\frac{IC_{50}}{K_i}$:\n$$ \\frac{IC_{50}}{K_i} = (2 - 1) + \\left( 2\\frac{[L]}{K_d} - \\frac{[L]}{K_d} \\right) $$\n$$ \\frac{IC_{50}}{K_i} = 1 + \\frac{[L]}{K_d} $$\nThis expression is the well-known Cheng-Prusoff equation for a pure competitive inhibitor.\n\nThe problem asks for the multiplicative shift factor $S \\equiv \\frac{IC_{50}}{K_i}$. Our derivation has produced the explicit form of this factor as a function of $[L]$ and $K_d$:\n$$ S = 1 + \\frac{[L]}{K_d} $$\nThis is the first part of the required answer.\n\nFor the second part, we must evaluate $S$ numerically using the provided values: $[L] = 2\\,\\text{nM}$ and $K_d = 1\\,\\text{nM}$.\n$$ S = 1 + \\frac{2\\,\\text{nM}}{1\\,\\text{nM}} $$\nThe units of concentration cancel, yielding a dimensionless shift factor:\n$$ S = 1 + 2 = 3 $$\nThis is the final numerical result.", "answer": "$$\n\\boxed{3}\n$$", "id": "2811040"}, {"introduction": "Upon binding its ligand, a steroid hormone receptor's primary function is to modulate gene expression by binding to specific DNA sequences known as hormone response elements (HREs). The stability of this protein-DNA complex, dictated by thermodynamics, directly influences the level of transcriptional regulation. This practice problem [@problem_id:2811016] explores this fundamental link, asking you to quantify how a specific mutation in an HRE alters the receptor's binding occupancy. By relating the change in binding free energy ($\\Delta \\Delta G$) to the equilibrium dissociation constant and occupancy, you will develop a quantitative intuition for how genetic variations in regulatory regions can impact cellular responses to hormonal signals.", "problem": "A nuclear receptor of the glucocorticoid receptor (GR) family binds a single glucocorticoid response element (GRE) half-site on DNA as a monomer with no cooperativity. Assume a dilute-regime where the free receptor concentration is well approximated by the total nuclear receptor concentration. The wild-type GRE half-site has a dissociation constant $K_{d}^{\\text{wt}} = 2\\,\\text{nM}$ under the experimental conditions. In the simplest sequence-additive (nearest-neighbor) model for proteinâ€“DNA recognition, the binding free energy to a site is the sum of independent contributions from adjacent base pairs. A single base-pair change in the GRE half-site increases the binding free energy by $\\Delta \\Delta G = 2\\,k_{B}T$ relative to wild type, where $k_{B}$ is the Boltzmann constant and $T$ is the absolute temperature. The nuclear receptor concentration is $[R] = 5\\,\\text{nM}$.\n\nUsing only fundamental equilibrium thermodynamics and mass action, and the fact that a shift in binding free energy by $\\Delta \\Delta G$ rescales the dissociation constant by a factor $\\exp\\!\\left(\\Delta \\Delta G/(k_{B}T)\\right)$, compute the equilibrium occupancy (probability of being bound) of the mutated GRE half-site at $[R] = 5\\,\\text{nM}$. Express your answer as a decimal fraction with no units, and round your final result to four significant figures.", "solution": "The problem statement is validated to be self-contained, scientifically grounded, and well-posed. It is based on fundamental principles of equilibrium thermodynamics and chemical kinetics as applied to biomolecular interactions. All necessary parameters are provided, and there are no internal contradictions or ambiguities. We proceed with the solution.\n\nThe problem requires the calculation of the equilibrium occupancy of a mutated DNA binding site by a nuclear receptor. The occupancy, denoted by $\\theta$, is defined as the fraction of DNA sites that are bound by the receptor at equilibrium.\n\nLet $R$ represent the receptor and $D_{\\text{mut}}$ represent the mutated DNA binding site. The binding equilibrium is described by the reversible reaction:\n$$\nR + D_{\\text{mut}} \\rightleftharpoons RD_{\\text{mut}}\n$$\nwhere $RD_{\\text{mut}}$ is the receptor-DNA complex.\n\nThe dissociation constant for this reaction, $K_{d}^{\\text{mut}}$, is defined by the law of mass action at equilibrium:\n$$\nK_{d}^{\\text{mut}} = \\frac{[R][D_{\\text{mut}}]}{[RD_{\\text{mut}}]}\n$$\nHere, $[R]$, $[D_{\\text{mut}}]$, and $[RD_{\\text{mut}}]$ represent the equilibrium concentrations of the free receptor, the free mutated DNA site, and the bound complex, respectively.\n\nThe occupancy, $\\theta_{\\text{mut}}$, is the ratio of the concentration of bound sites to the total concentration of sites:\n$$\n\\theta_{\\text{mut}} = \\frac{[RD_{\\text{mut}}]}{[D_{\\text{mut}}]_{\\text{total}}} = \\frac{[RD_{\\text{mut}}]}{[D_{\\text{mut}}] + [RD_{\\text{mut}}]}\n$$\nTo express $\\theta_{\\text{mut}}$ in terms of $[R]$ and $K_{d}^{\\text{mut}}$, we rearrange the dissociation constant expression to solve for $[D_{\\text{mut}}]$:\n$$\n[D_{\\text{mut}}] = \\frac{K_{d}^{\\text{mut}} [RD_{\\text{mut}}]}{[R]}\n$$\nSubstituting this into the occupancy equation yields:\n$$\n\\theta_{\\text{mut}} = \\frac{[RD_{\\text{mut}}]}{\\frac{K_{d}^{\\text{mut}} [RD_{\\text{mut}}]}{[R]} + [RD_{\\text{mut}}]}\n$$\nThe term $[RD_{\\text{mut}}]$ cancels from the numerator and denominator:\n$$\n\\theta_{\\text{mut}} = \\frac{1}{\\frac{K_{d}^{\\text{mut}}}{[R]} + 1} = \\frac{[R]}{[R] + K_{d}^{\\text{mut}}}\n$$\nThis is the standard Langmuir isotherm equation for a $1:1$ binding interaction. The problem states that we operate in a dilute regime where the free receptor concentration, $[R]$, can be approximated by the total receptor concentration. The given value is $[R] = 5\\,\\text{nM}$.\n\nNext, we must determine the value of $K_{d}^{\\text{mut}}$. The problem provides the dissociation constant for the wild-type site, $K_{d}^{\\text{wt}} = 2\\,\\text{nM}$, and the change in binding free energy for the mutation, $\\Delta \\Delta G = 2\\,k_{B}T$. It also provides the correct thermodynamic relationship between these quantities:\n$$\nK_{d}^{\\text{mut}} = K_{d}^{\\text{wt}} \\exp\\left(\\frac{\\Delta \\Delta G}{k_{B}T}\\right)\n$$\nAn increase in the Gibbs free energy of binding corresponds to a less favorable interaction, which is correctly reflected as an increase in the dissociation constant.\n\nSubstituting the given values:\n$$\nK_{d}^{\\text{mut}} = (2\\,\\text{nM}) \\times \\exp\\left(\\frac{2\\,k_{B}T}{k_{B}T}\\right) = (2\\,\\text{nM}) \\times \\exp(2)\n$$\nNow we have all the necessary components to calculate the occupancy of the mutated site, $\\theta_{\\text{mut}}$. We substitute $[R] = 5\\,\\text{nM}$ and $K_{d}^{\\text{mut}} = 2\\exp(2)\\,\\text{nM}$ into the occupancy formula:\n$$\n\\theta_{\\text{mut}} = \\frac{5\\,\\text{nM}}{5\\,\\text{nM} + 2\\exp(2)\\,\\text{nM}}\n$$\nThe units of concentration (nM) cancel, as expected for a dimensionless probability:\n$$\n\\theta_{\\text{mut}} = \\frac{5}{5 + 2\\exp(2)}\n$$\nWe now compute the numerical value. Using the value of Euler's number $e$, we find $\\exp(2) \\approx 7.389056$.\n$$\n\\theta_{\\text{mut}} = \\frac{5}{5 + 2 \\times 7.389056} = \\frac{5}{5 + 14.778112} = \\frac{5}{19.778112}\n$$\n$$\n\\theta_{\\text{mut}} \\approx 0.2528040\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\theta_{\\text{mut}} \\approx 0.2528\n$$\nThis is the final result for the equilibrium occupancy of the mutated GRE half-site.", "answer": "$$\n\\boxed{0.2528}\n$$", "id": "2811016"}]}